Clinmarksp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 74 days late).
- 2025not filed
- 202415/07/2025
- 202305/07/2024
- 202201/07/2023
- 202127/09/2022
- 202030/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
News
Clinmark at CPHI Milan 2026
6–8 October 2026 | Fiera Milano, Milan, Italy
Clinical Trials in Poland 2025: Is Education Keeping Pace with the Industry?
The results highlight a significant gap between students’ interest in clinical research and their perceived readiness to enter the profession.
The AI Act and Its Impact on Clinical Trials in Europe
Artificial Intelligence is rapidly transforming clinical trials, offering opportunities to improve patient recruitment, trial efficiency, and data analysis. The European Union has taken a significant step to regulate this technology by introducing the AI Act, the world’s first comprehensive legal framework for AI. We are now one year into its phased implementation, and sponsors, CROs, and other stakeholders must carefully navigate its implications for ongoing and future clinical trials.
Participation in the opening of PolTREG’s own state-of-the-art cell and gene therapy production plant
Last Monday our team: Jarosław Kasprowicz, PhD, MBA , Monika Mastrzykowska and Marta Rzeszotarska had a great pleasure to participate in the opening of PolTREG S.A. own state-of-the art cell and gene therapy manufacturing facility, which is one of the most modern plants in Europe.
Participation in first in Poland Clinical Trials for Medical Device Conference in Warsaw
Yesterday our team ( Joanna Ruelland and Kaja Sieracka ) participated in first in Poland Clinical Trails for Medical Device Conference in Warsaw.
CEBioForum2023! Meet our team during one of the biggest Biotech events in Poland
Great to be present during one of the biggest Biotech events in PL. Meet us – CLINMARK – Clinical Research and Consulting and let’s talk about how we can support your projects in clinical trials.
Industry
Offer
- Clinical trials
- Project management
- Clinical monitoring
- Medical monitoring
- Data management
- Pharmacovigilance
- Biostatistics
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
In the case of a one-person management board – the sole member of the management board independently; in the case of a multi-member management board – the President of the Management Board independently, or two members of the management board jointly, or a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Kamila Marta Wasilukage 50 | 100 | $2,701.24 | 20% |
Marek Roland Wasilukage 52 | 400 | $10,804.97 | 80% |
Marek Roland Wasiluk and Kamila Marta Wasiluk hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2008-03-19.
05 1600 1462 1889 4980 5000 0003
11 1020 1169 0000 8402 0277 2820- 15 1440 1101 0000 0000 0731 3365
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $39,459.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,459$3,459 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,661$4,661 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,645$3,645 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Satagrosp. z o.o. | $1,365,254.65 | satagro.pl | ||
| Instytut Materiałów Budowlanych i Technologii Betonusp. z o.o. | $948,903.87 | imbitb.pl | ||
| 50bio.Comsp. z o.o. | $670,101.32 | 50bio.com | ||
| Airway MedixS.A. | $512,838.82 | airway-medix.com | ||
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| Cezamat Pwsp. z o.o. | $119,656.05 | cezamat.eu | ||
| CPJS - Centrum Promocji Jakości Stalisp. z o.o. | $90,239.54 | epstal.pl | ||
| SimplicardiacS.A. | $28,951.71 | simplicardiac.com | ||
| Grera Connectsp. z o.o. | $39.66 | meshr.io |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-09 | Address change (Ul. Wiktorska 63, 02-587, Warszawa → Ul. Puławska 303, 02-785, Warszawa) | |
| 2022-03-26 | Address change (Aleja Komisji Edukacji Narodowej 47/13, 02-797, Warszawa → Ul. Wiktorska 63, 02-587, Warszawa) | |
| 2017-03-13 | Address change (Al. Komisji Edukacji Narodowej 88/102, 02-777, Warszawa → Aleja Komisji Edukacji Narodowej 47/13, 02-797, Warszawa) | |
| 2017-03-13 | PKD change (Removed: 57 codes) | |
| 2008-03-11 | Entered in the register |
FAQ
Last updated: 2026-04-15